New twists on long noncoding RNAs: from mobile elements to motile cancer cells

References

• Ginger MR, Gonzalez-Rimbau MF, Gay JP, et al. Persistent changes in gene expression induced by estrogen and progesterone in the rat mammary gland. Mol Endocrinol. 2001;15(11):1993–2009.
   PubMedGoogle Scholar
• Mattick JS. Non-coding RNAs: the architects of eukaryotic complexity. EMBO Rep. 2001;2(11):986–991.
   PubMed Web of Science ®Google Scholar
• Ginger MR, Rosen JM. Pregnancy-induced changes in cell-fate in the mammary gland. Breast Cancer Res. 2003;5(4):192–197.
   PubMed Web of Science ®Google Scholar
• Ginger MR, Shore AN, Contreras A, et al. A noncoding RNA is a potential marker of cell fate during mammary gland development. Proc Natl Acad Sci U S A. 2006;103(15):5781–5786.
   PubMed Web of Science ®Google Scholar
• Shore AN, Kabotyanski EB, Roarty K, et al. Pregnancy-induced noncoding RNA (PINC) associates with polycomb repressive complex 2 and regulates mammary epithelial differentiation. PLoS Genet. 2012;8(7):e1002840.
   PubMed Web of Science ®Google Scholar
• Amin V, Harris RA, Onuchic V, et al. Epigenomic footprints across 111 reference epigenomes reveal tissue-specific epigenetic regulation of lincRNAs. Nat Commun. 2015;6:6370.
   PubMed Web of Science ®Google Scholar
• Yao RW, Wang Y, Chen LL. Cellular functions of long noncoding RNAs. Nat Cell Biol. 2019;21(5):542–551.
   PubMed Web of Science ®Google Scholar
• Ma L, Cao J, Liu L, et al. LncBook: a curated knowledgebase of human long non-coding RNAs. Nucleic Acids Res. 2019;47(D1):D128–D134.
   PubMed Web of Science ®Google Scholar
• Huang QY, Liu GF, Qian XL, et al. Long non-coding RNA: dual effects on breast cancer metastasis and clinical applications. Cancers (Basel). 2019;11(11). DOI: 10.3390/cancers11111802.
   Web of Science ®Google Scholar
• Derrien T, Johnson R, Bussotti G, et al. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res. 2012;22(9):1775–1789.
   PubMed Web of Science ®Google Scholar
• Kopp F, Mendell JT. Functional classification and experimental dissection of long noncoding RNAs. Cell. 2018;172(3):393–407.
   PubMed Web of Science ®Google Scholar
• Khalil AM, Guttman M, Huarte M, et al. Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc Natl Acad Sci USA. 2009;106(28):11667–11672.
   PubMed Web of Science ®Google Scholar
• Gupta RA, Shah N, Wang KC, et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature. 2010;464(7291):1071–1076.
   PubMed Web of Science ®Google Scholar
• Shi Y, Wang XX, Zhuang YW, et al. Structure of the PRC2 complex and application to drug discovery. Acta Pharmacol Sin. 2017;38(7):963–976.
   PubMed Web of Science ®Google Scholar
• Tsai MC, Manor O, Wan Y, et al. Long noncoding RNA as modular scaffold of histone modification complexes. Science. 2010;329(5992):689–693.
   PubMed Web of Science ®Google Scholar
• Sorensen KP, Thomassen M, Tan Q, et al. Long non-coding RNA HOTAIR is an independent prognostic marker of metastasis in estrogen receptor-positive primary breast cancer. Breast Cancer Res Treat. 2013;142(3):529–536.
   PubMed Web of Science ®Google Scholar
• Padua Alves C, Fonseca AS, Muys BR, et al. Brief report: the lincRNA Hotair is required for epithelial-to-mesenchymal transition and stemness maintenance of cancer cell lines. Stem Cells. 2013;31(12):2827–2832.
   PubMed Web of Science ®Google Scholar
• Kim HJ, Lee DW, Yim GW, et al. Long non-coding RNA HOTAIR is associated with human cervical cancer progression. Int J Oncol. 2015;46(2):521–530.
   PubMed Web of Science ®Google Scholar
• Luo M, Li Z, Wang W, et al. Long non-coding RNA H19 increases bladder cancer metastasis by associating with EZH2 and inhibiting E-cadherin expression. Cancer Lett. 2013;333(2):213–221.
   PubMed Web of Science ®Google Scholar
• Fan Y, Shen B, Tan M, et al. TGF-beta-induced upregulation of malat1 promotes bladder cancer metastasis by associating with suz12. Clin Cancer Res. 2014;20(6):1531–1541.
   PubMed Web of Science ®Google Scholar
• Li W, Zhang Z, Liu X, et al. The FOXN3-NEAT1-SIN3A repressor complex promotes progression of hormonally responsive breast cancer. J Clin Invest. 2017;127(9):3421–3440.
   PubMed Web of Science ®Google Scholar
• Mondal T, Subhash S, Vaid R, et al. MEG3 long noncoding RNA regulates the TGF-beta pathway genes through formation of RNA-DNA triplex structures. Nat Commun. 2015;6:7743.
   PubMed Web of Science ®Google Scholar
• Qi D, Li J, Que B, et al. Long non-coding RNA DBCCR1-003 regulate the expression of DBCCR1 via DNMT1 in bladder cancer. Cancer Cell Int. 2016;16:81.
   PubMed Web of Science ®Google Scholar
• Boque-Sastre R, Soler M, Oliveira-Mateos C, et al. Head-to-head antisense transcription and R-loop formation promotes transcriptional activation. Proc Natl Acad Sci U S A. 2015;112(18):5785–5790.
   PubMed Web of Science ®Google Scholar
• Jia X, Wang Z, Qiu L, et al. Upregulation of LncRNA-HIT promotes migration and invasion of non-small cell lung cancer cells by association with ZEB1. Cancer Med. 2016;5(12):3555–3563.
   PubMed Web of Science ®Google Scholar
• Yu L, Fang F, Lu S, et al. lncRNA-HIT promotes cell proliferation of non-small cell lung cancer by association with E2F1. Cancer Gene Ther. 2017;24(5):221–226.
   PubMed Web of Science ®Google Scholar
• Sakai S, Ohhata T, Kitagawa K, et al. Long noncoding RNA ELIT-1 acts as a Smad3 cofactor to facilitate TGF-β/Smad signaling and promote epithelial-mesenchymal transition. Cancer Res. 2019;79(11):2821–2838.
   PubMedGoogle Scholar
• Deng SJ, Chen HY, Ye Z, et al. Hypoxia-induced LncRNA-BX111 promotes metastasis and progression of pancreatic cancer through regulating ZEB1 transcription. Oncogene. 2018;37(44):5811–5828.
   PubMed Web of Science ®Google Scholar
• Kino T, Hurt DE, Ichijo T, et al. Noncoding RNA gas5 is a growth arrest- and starvation-associated repressor of the glucocorticoid receptor. Sci Signal. 2010;3(107):ra8.
   PubMed Web of Science ®Google Scholar
• Han L, Ma P, Liu SM, et al. Circulating long noncoding RNA GAS5 as a potential biomarker in breast cancer for assessing the surgical effects. Tumour Biol. 2016;37(5):6847–6854.
   PubMedGoogle Scholar
• Ji J, Dai X, Yeung SJ, et al. The role of long non-coding RNA GAS5 in cancers. Cancer Manag Res. 2019;11:2729–2737.
   PubMed Web of Science ®Google Scholar
• Martianov I, Ramadass A, Serra Barros A, et al. Repression of the human dihydrofolate reductase gene by a non-coding interfering transcript. Nature. 2007;445(7128):666–670.
   PubMed Web of Science ®Google Scholar
• Nie L, Wu HJ, Hsu JM, et al. Long non-coding RNAs: versatile master regulators of gene expression and crucial players in cancer. Am J Transl Res. 2012;4(2):127–150.
   PubMed Web of Science ®Google Scholar
• Calo E, Flynn RA, Martin L, et al. RNA helicase DDX21 coordinates transcription and ribosomal RNA processing. Nature. 2015;518(7538):249–253.
   PubMed Web of Science ®Google Scholar
• Andersson R, Gebhard C, Miguel-Escalada I, et al. An atlas of active enhancers across human cell types and tissues. Nature. 2014;507(7493):455–461.
   PubMed Web of Science ®Google Scholar
• Pefanis E, Wang J, Rothschild G, et al. Noncoding RNA transcription targets AID to divergently transcribed loci in B cells. Nature. 2014;514(7522):389–393.
   PubMed Web of Science ®Google Scholar
• Pefanis E, Wang J, Rothschild G, et al. RNA exosome-regulated long non-coding RNA transcription controls super-enhancer activity. Cell. 2015;161(4):774–789.
   PubMed Web of Science ®Google Scholar
• Li W, Notani D, Rosenfeld MG. Enhancers as non-coding RNA transcription units: recent insights and future perspectives. Nat Rev Genet. 2016;17(4):207–223.
   PubMed Web of Science ®Google Scholar
• De Santa F, Barozzi I, Mietton F, et al. A large fraction of extragenic RNA pol II transcription sites overlap enhancers. PLoS Biol. 2010;8(5):e1000384.
   PubMed Web of Science ®Google Scholar
• Whyte WA, Orlando DA, Hnisz D, et al. Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell. 2013;153(2):307–319.
   PubMed Web of Science ®Google Scholar
• Sigova AA, Abraham BJ, Ji X, et al. Transcription factor trapping by RNA in gene regulatory elements. Science. 2015;350(6263):978–981.
   PubMed Web of Science ®Google Scholar
• Lemay JF, Larochelle M, Marguerat S, et al. The RNA exosome promotes transcription termination of backtracked RNA polymerase II. Nat Struct Mol Biol. 2014;21(10):919–926.
   PubMed Web of Science ®Google Scholar
• Arner E, Daub CO, Vitting-Seerup K, et al. Transcribed enhancers lead waves of coordinated transcription in transitioning mammalian cells. Science. 2015;347(6225):1010–1014.
   PubMed Web of Science ®Google Scholar
• Kim YJ, Xie P, Cao L, et al. Global transcriptional activity dynamics reveal functional enhancer RNAs. Genome Res. 2018;28(12):1799–1811.
   PubMed Web of Science ®Google Scholar
• Li G-Y, Wang W, Sun J-Y, et al. Long non-coding RNAs AC026904.1 and UCA1: a “one-two punch” for TGF-β-induced SNAI2 activation and epithelial-mesenchymal transition in breast cancer. Theranostics. 2018;8(10):2846–2861.
   PubMed Web of Science ®Google Scholar
• Lieberman-Aiden E, van Berkum NL, Williams L, et al. Comprehensive mapping of long-range interactions reveals folding principles of the human genome. Science. 2009;326(5950):289–293.
   PubMed Web of Science ®Google Scholar
• Bhan A, Mandal SS. LncRNA HOTAIR: A master regulator of chromatin dynamics and cancer. Biochim Biophys Acta. 2015;1856(1):151–164.
   PubMed Web of Science ®Google Scholar
• Rinn JL, Kertesz M, Wang JK, et al. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell. 2007;129(7):1311–1323.
   PubMed Web of Science ®Google Scholar
• Wang KC, Yang YW, Liu B, et al. A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression. Nature. 2011;472(7341):120–124.
   PubMed Web of Science ®Google Scholar
• Soibam B. Super-lncRNAs: identification of lncRNAs that target super-enhancers via RNA:DNA:DNA triplex formation. RNA. 2017;23(11):1729–1742.
   PubMed Web of Science ®Google Scholar
• Matera AG, Wang Z. A day in the life of the spliceosome. Nat Rev Mol Cell Biol. 2014;15(2):108–121.
   PubMed Web of Science ®Google Scholar
• He RZ, Luo DX, Mo YY. Emerging roles of lncRNAs in the post-transcriptional regulation in cancer. Genes Dis. 2019;6(1):6–15.
   PubMed Web of Science ®Google Scholar
• Tazi J, Bakkour N, Stamm S. Alternative splicing and disease. Biochim Biophys Acta. 2009;1792(1):14–26.
   PubMed Web of Science ®Google Scholar
• Hutchinson JN, Ensminger AW, Clemson CM, et al. A screen for nuclear transcripts identifies two linked noncoding RNAs associated with SC35 splicing domains. BMC Genomics. 2007;8:39.
   PubMed Web of Science ®Google Scholar
• Cooper DR, Carter G, Li P, et al. Long non-coding RNA NEAT1 associates with SRp40 to temporally regulate PPARgamma2 splicing during adipogenesis in 3T3-L1 Cells. Genes (Basel). 2014;5(4):1050–1063.
   PubMed Web of Science ®Google Scholar
• Tripathi V, Ellis JD, Shen Z, et al. The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. Mol Cell. 2010;39(6):925–938.
   PubMed Web of Science ®Google Scholar
• Bernard D, Prasanth KV, Tripathi V, et al. A long nuclear-retained non-coding RNA regulates synaptogenesis by modulating gene expression. Embo J. 2010;29(18):3082–3093.
   PubMed Web of Science ®Google Scholar
• Romero-Barrios N, Legascue MF, Benhamed M, et al. Splicing regulation by long noncoding RNAs. Nucleic Acids Res. 2018;46(5):2169–2184.
   PubMed Web of Science ®Google Scholar
• Ji Q, Zhang L, Liu X, et al. Long non-coding RNA MALAT1 promotes tumour growth and metastasis in colorectal cancer through binding to SFPQ and releasing oncogene PTBP2 from SFPQ/PTBP2 complex. Br J Cancer. 2014;111(4):736–748.
   PubMed Web of Science ®Google Scholar
• Malakar P, Shilo A, Mogilevsky A, et al. Long Noncoding RNA MALAT1 Promotes Hepatocellular Carcinoma Development by SRSF1 Upregulation and mTOR Activation. Cancer Res. 2017;77(5):1155–1167.
   PubMed Web of Science ®Google Scholar
• Gordon MA, Babbs B, Cochrane DR, et al. The long non-coding RNA MALAT1 promotes ovarian cancer progression by regulating RBFOX2-mediated alternative splicing. Mol Carcinog. 2019;58(2):196–205.
   PubMed Web of Science ®Google Scholar
• Kong J, Sun W, Li C, et al. Long non-coding RNA LINC01133 inhibits epithelial-mesenchymal transition and metastasis in colorectal cancer by interacting with SRSF6. Cancer Lett. 2016;380(2):476–484.
   PubMed Web of Science ®Google Scholar
• Khorkova O, Myers AJ, Hsiao J, et al. Natural antisense transcripts. Hum Mol Genet. 2014;23(R1):R54–63.
   PubMedGoogle Scholar
• Villamizar O, Chambers CB, Riberdy JM, et al. Long noncoding RNA Saf and splicing factor 45 increase soluble Fas and resistance to apoptosis. Oncotarget. 2016;7(12):13810–13826.
   PubMedGoogle Scholar
• Beltran M, Puig I, Pena C, et al. A natural antisense transcript regulates Zeb2/Sip1 gene expression during Snail1-induced epithelial-mesenchymal transition. Genes Dev. 2008;22(6):756–769.
   PubMed Web of Science ®Google Scholar
• Gonzalez I, Munita R, Agirre E, et al. A lncRNA regulates alternative splicing via establishment of a splicing-specific chromatin signature. Nat Struct Mol Biol. 2015;22(5):370–376.
   PubMed Web of Science ®Google Scholar
• Xu Q, Deng F, Qin Y, et al. Long non-coding RNA regulation of epithelial-mesenchymal transition in cancer metastasis. Cell Death Dis. 2016;7(6):e2254.
   PubMedGoogle Scholar
• Humphries B, Yang C. The microRNA-200 family: small molecules with novel roles in cancer development, progression and therapy. Oncotarget. 2015;6(9):6472–6498.
   PubMedGoogle Scholar
• Gregory PA, Bert AG, Paterson EL, et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol. 2008;10(5):593–601.
   PubMed Web of Science ®Google Scholar
• Park SM, Gaur AB, Lengyel E, et al. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev. 2008;22(7):894–907.
   PubMed Web of Science ®Google Scholar
• Gibbons DL, Lin W, Creighton CJ, et al. Contextual extracellular cues promote tumor cell EMT and metastasis by regulating miR-200 family expression. Genes Dev. 2009;23(18):2140–2151.
   PubMed Web of Science ®Google Scholar
• Xie H, Ma H, Zhou D. Plasma HULC as a promising novel biomarker for the detection of hepatocellular carcinoma. Biomed Res Int. 2013;2013:136106.
   PubMed Web of Science ®Google Scholar
• Panzitt K, Tschernatsch MM, Guelly C, et al. Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA. Gastroenterology. 2007;132(1):330–342.
   PubMed Web of Science ®Google Scholar
• Li SP, Xu HX, Yu Y, et al. LncRNA HULC enhances epithelial-mesenchymal transition to promote tumorigenesis and metastasis of hepatocellular carcinoma via the miR-200a-3p/ZEB1 signaling pathway. Oncotarget. 2016;7(27):42431–42446.
   PubMed Web of Science ®Google Scholar
• Yuan JH, Yang F, Wang F, et al. A long noncoding RNA activated by TGF-beta promotes the invasion-metastasis cascade in hepatocellular carcinoma. Cancer Cell. 2014;25(5):666–681.
   PubMed Web of Science ®Google Scholar
• Li RH, Chen M, Liu J, et al. Long noncoding RNA ATB promotes the epithelial-mesenchymal transition by upregulating the miR-200c/Twist1 axe and predicts poor prognosis in breast cancer. Cell Death Dis. 2018;9(12):1171.
   PubMed Web of Science ®Google Scholar
• Richards EJ, Zhang G, Li ZP, et al. Long non-coding RNAs (LncRNA) regulated by transforming growth factor (TGF) beta: lncRNA-hit-mediated TGFbeta-induced epithelial to mesenchymal transition in mammary epithelia. J Biol Chem. 2015;290(11):6857–6867.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Feng C, Li Y, et al. LncRNA H19 promotes lung cancer proliferation and metastasis by inhibiting miR-200a function. Mol Cell Biochem. 2019;460(1–2):1–8.
   PubMed Web of Science ®Google Scholar
• Liang WC, Fu WM, Wong CW, et al. The lncRNA H19 promotes epithelial to mesenchymal transition by functioning as miRNA sponges in colorectal cancer. Oncotarget. 2015;6(26):22513–22525.
   PubMedGoogle Scholar
• Grelet S, Link LA, Howley B, et al. A regulated PNUTS mRNA to lncRNA splice switch mediates EMT and tumour progression. Nat Cell Biol. 2017;19(9):1105–1115.
   PubMed Web of Science ®Google Scholar
• Eades G, Wolfson B, Zhang Y, et al. lincRNA-RoR and miR-145 regulate invasion in triple-negative breast cancer via targeting ARF6. Mol Cancer Res. 2015;13(2):330–338.
   PubMed Web of Science ®Google Scholar
• Hou P, Zhao Y, Li Z, et al. LincRNA-ROR induces epithelial-to-mesenchymal transition and contributes to breast cancer tumorigenesis and metastasis. Cell Death Dis. 2014;5:e1287.
   PubMed Web of Science ®Google Scholar
• Lei H, Gao Y, Xu X. LncRNA TUG1 influences papillary thyroid cancer cell proliferation, migration and EMT formation through targeting miR-145. Acta Biochim Biophys Sin (Shanghai). 2017;49(7):588–597.
   PubMed Web of Science ®Google Scholar
• Ge X, Li GY, Jiang L, et al. Long noncoding RNA CAR10 promotes lung adenocarcinoma metastasis via miR-203/30/SNAI axis. Oncogene. 2019;38(16):3061–3076.
   PubMed Web of Science ®Google Scholar
• Lin C, Zhang S, Wang Y, et al. Functional role of a novel long noncoding RNA TTN-AS1 in esophageal squamous cell carcinoma progression and metastasis. Clin Cancer Res. 2018;24(2):486–498.
   PubMed Web of Science ®Google Scholar
• Chen Y, Tian T, Li ZY, et al. FSCN1 is an effective marker of poor prognosis and a potential therapeutic target in human tongue squamous cell carcinoma. Cell Death Dis. 2019;10(5):356.
   PubMedGoogle Scholar
• Jiang L, Wang R, Fang L, et al. HCP5 is a SMAD3-responsive long non-coding RNA that promotes lung adenocarcinoma metastasis via miR-203/SNAI axis. Theranostics. 2019;9(9):2460–2474.
   PubMed Web of Science ®Google Scholar
• Dong H, Hu J, Zou K, et al. Activation of LncRNA TINCR by H3K27 acetylation promotes Trastuzumab resistance and epithelial-mesenchymal transition by targeting MicroRNA-125b in breast Cancer. Mol Cancer. 2019;18(1):3.
   PubMed Web of Science ®Google Scholar
• Liu YW, Sun M, Xia R, et al. LincHOTAIR epigenetically silences miR34a by binding to PRC2 to promote the epithelial-to-mesenchymal transition in human gastric cancer. Cell Death Dis. 2015;6:e1802.
   PubMed Web of Science ®Google Scholar
• Terashima M, Ishimura A, Wanna-Udom S, et al. MEG8 long noncoding RNA contributes to epigenetic progression of the epithelial-mesenchymal transition of lung and pancreatic cancer cells. J Biol Chem. 2018;293(47):18016–18030.
   PubMed Web of Science ®Google Scholar
• Terashima M, Tange S, Ishimura A, et al. MEG3 long noncoding RNA contributes to the epigenetic regulation of epithelial-mesenchymal transition in lung cancer cell lines. J Biol Chem. 2017;292(1):82–99.
   PubMed Web of Science ®Google Scholar
• Wang L, Wei Z, Wu K, et al. Long noncoding RNA B3GALT5-AS1 suppresses colon cancer liver metastasis via repressing microRNA-203. Aging (Albany NY). 2018;10(12):3662–3682.
   PubMedGoogle Scholar
• Huang J, Zhang A, Ho TT, et al. Linc-RoR promotes c-Myc expression through hnRNP I and AUF1. Nucleic Acids Res. 2016;44(7):3059–3069.
   PubMed Web of Science ®Google Scholar
• Zhang A, Zhou N, Huang J, et al. The human long non-coding RNA-RoR is a p53 repressor in response to DNA damage. Cell Res. 2013;23(3):340–350.
   PubMed Web of Science ®Google Scholar
• Cao L, Zhang P, Li J, et al. LAST, a c-Myc-inducible long noncoding RNA, cooperates with CNBP to promote CCND1 mRNA stability in human cells. Elife. 2017;pii:e30433.
   Web of Science ®Google Scholar
• Li X, Ma C, Zhang L, et al. LncRNAAC132217.4, a KLF8-regulated long non-coding RNA, facilitates oral squamous cell carcinoma metastasis by upregulating IGF2 expression. Cancer Lett. 2017;407:45–56.
   PubMed Web of Science ®Google Scholar
• Jadaliha M, Gholamalamdari O, Tang W, et al. A natural antisense lncRNA controls breast cancer progression by promoting tumor suppressor gene mRNA stability. PLoS Genet. 2018;14(11):e1007802.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Liu Y, Lin L, et al. The lncRNA MACC1-AS1 promotes gastric cancer cell metabolic plasticity via AMPK/Lin28 mediated mRNA stability of MACC1. Mol Cancer. 2018;17(1):69.
   PubMed Web of Science ®Google Scholar
• Lan Y, Xiao X, He Z, et al. Long noncoding RNA OCC-1 suppresses cell growth through destabilizing HuR protein in colorectal cancer. Nucleic Acids Res. 2018;46(11):5809–5821.
   PubMed Web of Science ®Google Scholar
• Chen J, Liu L, Wei G, et al. The long noncoding RNA ASNR regulates degradation of Bcl-2 mRNA through its interaction with AUF1. Sci Rep. 2016;6:32189.
   PubMed Web of Science ®Google Scholar
• Gong C, Maquat LE. lncRNAs transactivate STAU1-mediated mRNA decay by duplexing with 3ʹ UTRs via Alu elements. Nature. 2011;470(7333):284–288.
   PubMed Web of Science ®Google Scholar
• Gregory TR. Synergy between sequence and size in large-scale genomics. Nat Rev Genet. 2005;6(9):699–708.
   PubMed Web of Science ®Google Scholar
• Goerner-Potvin P, Bourque G. Computational tools to unmask transposable elements. Nat Rev Genet. 2018;19(11):688–704.
   PubMed Web of Science ®Google Scholar
• Fedoroff NV. Presidential address. Transposable elements, epigenetics, and genome evolution. Science. 2012;338(6108):758–767.
   PubMed Web of Science ®Google Scholar
• Tubio JMC, Li Y, Ju YS, et al. Mobile DNA in cancer. Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes. Science. 2014;345(6196):1251343.
   PubMed Web of Science ®Google Scholar
• Carrieri C, Cimatti L, Biagioli M, et al. Long non-coding antisense RNA controls Uchl1 translation through an embedded SINEB2 repeat. Nature. 2012;491(7424):454–457.
   PubMed Web of Science ®Google Scholar
• Elbarbary RA, Lucas BA, Maquat LE. Retrotransposons as regulators of gene expression. Science. 2016;351(6274):aac7247.
   PubMed Web of Science ®Google Scholar
• Kelley D, Rinn J. Transposable elements reveal a stem cell-specific class of long noncoding RNAs. Genome Biol. 2012;13(11):R107.
   PubMed Web of Science ®Google Scholar
• Hinnebusch AG, Ivanov IP, Sonenberg N. Translational control by 5ʹ-untranslated regions of eukaryotic mRNAs. Science. 2016;352(6292):1413–1416.
   PubMed Web of Science ®Google Scholar
• Lubelsky Y, Ulitsky I. Sequences enriched in Alu repeats drive nuclear localization of long RNAs in human cells. Nature. 2018;555(7694):107–111.
   PubMed Web of Science ®Google Scholar
• Nguyen TM, Kabotyanski EB, Reineke LC, et al. The SINEB1 element in the long non-coding RNA Malat1 is necessary for TDP-43 proteostasis. Nucleic Acids Res. 2020;48(5):2621–2642.
   Web of Science ®Google Scholar
• Chillon I, Pyle AM. Inverted repeat Alu elements in the human lincRNA-p21 adopt a conserved secondary structure that regulates RNA function. Nucleic Acids Res. 2016;44(19):9462–9471.
   PubMed Web of Science ®Google Scholar
• Kelley DR, Hendrickson DG, Tenen D, et al. Transposable elements modulate human RNA abundance and splicing via specific RNA-protein interactions. Genome Biol. 2014;15(12):537.
   PubMed Web of Science ®Google Scholar
• An HJ, Lee D, Lee KH, et al. The association of Alu repeats with the generation of potential AU-rich elements (ARE) at 3ʹ untranslated regions. BMC Genomics. 2004;5(1):97.
   PubMedGoogle Scholar
• Chai Y, Liu J, Zhang Z, et al. HuR-regulated lncRNA NEAT1 stability in tumorigenesis and progression of ovarian cancer. Cancer Med. 2016;5(7):1588–1598.
   PubMed Web of Science ®Google Scholar
• Sorek R, Ast G, Graur D. Alu-containing exons are alternatively spliced. Genome Res. 2002;12(7):1060–1067.
   PubMed Web of Science ®Google Scholar
• Zarnack K, Konig J, Tajnik M, et al. Direct competition between hnRNP C and U2AF65 protects the transcriptome from the exonization of Alu elements. Cell. 2013;152(3):453–466.
   PubMed Web of Science ®Google Scholar
• Lehnert S, Van Loo P, Thilakarathne PJ, et al. Evidence for co-evolution between human microRNAs and Alu-repeats. PLoS One. 2009;4(2):e4456.
   PubMed Web of Science ®Google Scholar
• Li RK, Gao J, Guo LH, et al. PTENP1 acts as a ceRNA to regulate PTEN by sponging miR-19b and explores the biological role of PTENP1 in breast cancer. Cancer Gene Ther. 2017;24(7):309–315.
   PubMed Web of Science ®Google Scholar
• Poliseno L, Salmena L, Zhang J, et al. A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature. 2010;465(7301):1033–1038.
   PubMed Web of Science ®Google Scholar
• Wang J, Liu X, Wu H, et al. CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer. Nucleic Acids Res. 2010;38(16):5366–5383.
   PubMed Web of Science ®Google Scholar
• Lee JY, Ji Z, Tian B. Phylogenetic analysis of mRNA polyadenylation sites reveals a role of transposable elements in evolution of the 3ʹ-end of genes. Nucleic Acids Res. 2008;36(17):5581–5590.
   PubMed Web of Science ®Google Scholar
• Ziegler C, Kretz M. The more the merrier-complexity in long non-coding RNA loci. Front Endocrinol (Lausanne). 2017;8:90.
   PubMed Web of Science ®Google Scholar
• Xiang JF, Yin QF, Chen T, et al. Human colorectal cancer-specific CCAT1-L lncRNA regulates long-range chromatin interactions at the MYC locus. Cell Res. 2014;24(5):513–531.
   PubMed Web of Science ®Google Scholar
• Chishima T, Iwakiri J, Hamada M. Identification of transposable elements contributing to tissue-specific expression of long non-coding RNAs. Genes (Basel). 2018;9(1). DOI:10.3390/genes9010023
   PubMed Web of Science ®Google Scholar
• Faulkner GJ, Kimura Y, Daub CO, et al. The regulated retrotransposon transcriptome of mammalian cells. Nat Genet. 2009;41(5):563–571.
   PubMed Web of Science ®Google Scholar
• Jiang JC, Upton KR. Human transposons are an abundant supply of transcription factor binding sites and promoter activities in breast cancer cell lines. Mob DNA. 2019;10:16.
   PubMed Web of Science ®Google Scholar
• Andreasen PA, Kjoller L, Christensen L, et al. The urokinase-type plasminogen activator system in cancer metastasis: a review. Int J Cancer. 1997;72(1):1–22.
   PubMed Web of Science ®Google Scholar
• Hussain S, Bedekovics T, Chesi M, et al. UCHL1 is a biomarker of aggressive multiple myeloma required for disease progression. Oncotarget. 2015;6(38):40704–40718.
   PubMedGoogle Scholar
• Zeng J, Xiang W, Zhang Y, et al. Ubiquitous expressed transcript promotes tumorigenesis by acting as a positive modulator of the polycomb repressive complex 2 in clear cell renal cell carcinoma. BMC Cancer. 2019;19(1):874.
   PubMed Web of Science ®Google Scholar
• Yin J, Luo W, Zeng X, et al. UXT-AS1-induced alternative splicing of UXT is associated with tumor progression in colorectal cancer. Am J Cancer Res. 2017;7(3):462–472.
   PubMed Web of Science ®Google Scholar
• Grote P, Wittler L, Hendrix D, et al. The tissue-specific lncRNA Fendrr is an essential regulator of heart and body wall development in the mouse. Dev Cell. 2013;24(2):206–214.
   PubMed Web of Science ®Google Scholar
• Holdt LM, Hoffmann S, Sass K, et al. Alu elements in ANRIL non-coding RNA at chromosome 9p21 modulate atherogenic cell functions through trans-regulation of gene networks. PLoS Genet. 2013;9(7):e1003588.
   PubMed Web of Science ®Google Scholar
• Hao YR, Zhang DJ, Fu ZM, et al. Long non-coding RNA ANRIL promotes proliferation, clonogenicity, invasion and migration of laryngeal squamous cell carcinoma by regulating miR-181a/Snai2 axis. Regen Ther. 2019;11:282–289.
   PubMed Web of Science ®Google Scholar
• Miao L, Huang Z, Zengli Z, et al. Loss of long noncoding RNA FOXF1-AS1 regulates epithelial-mesenchymal transition, stemness and metastasis of non-small cell lung cancer cells. Oncotarget. 2016;7(42):68339–68349.
   PubMedGoogle Scholar
• Lau CC, Sun T, Ching AK, et al. Viral-human chimeric transcript predisposes risk to liver cancer development and progression. Cancer Cell. 2014;25(3):335–349.
   PubMed Web of Science ®Google Scholar
• Nguyen TM, Kabotyanski EB, Dou Y, et al. FGFR1-activated translation of WNT pathway components with structured 5ʹ UTRs is vulnerable to inhibition of EIF4A-dependent translation initiation. Cancer Res. 2018;78(15):4229–4240.
   PubMed Web of Science ®Google Scholar
• Mariner PD, Walters RD, Espinoza CA, et al. Human Alu RNA is a modular transacting repressor of mRNA transcription during heat shock. Mol Cell. 2008;29(4):499–509.
   PubMed Web of Science ®Google Scholar
• Chen R, Nishimura MC, Kharbanda S, et al. Hominoid-specific enzyme GLUD2 promotes growth of IDH1R132H glioma. Proc Natl Acad Sci U S A. 2014;111(39):14217–14222.
   PubMed Web of Science ®Google Scholar
• Kim DD, Kim TT, Walsh T, et al. Widespread RNA editing of embedded alu elements in the human transcriptome. Genome Res. 2004;14(9):1719–1725.
   PubMed Web of Science ®Google Scholar
• Levanon EY, Eisenberg E, Yelin R, et al. Systematic identification of abundant A-to-I editing sites in the human transcriptome. Nat Biotechnol. 2004;22(8):1001–1005.
   PubMed Web of Science ®Google Scholar
• Xu LD, Ohman M. ADAR1 editing and its role in cancer. Genes (Basel). 2018;10(1). DOI:10.3390/genes10010012
   PubMed Web of Science ®Google Scholar
• Bennett CF, Swayze EE. RNA targeting therapeutics: molecular mechanisms of antisense oligonucleotides as a therapeutic platform. Annu Rev Pharmacol Toxicol. 2010;50:259–293.
   PubMed Web of Science ®Google Scholar
• Bennett CF, Baker BF, Pham N, et al. Pharmacology of Antisense Drugs. Annu Rev Pharmacol Toxicol. 2017;57:81–105.
   PubMed Web of Science ®Google Scholar
• Stein CA, Subasinghe C, Shinozuka K, et al. Physicochemical properties of phosphorothioate oligodeoxynucleotides. Nucleic Acids Res. 1988;16(8):3209–3221.
   PubMed Web of Science ®Google Scholar
• Monia BP, Lesnik EA, Gonzalez C, et al. Evaluation of 2ʹ-modified oligonucleotides containing 2ʹ-deoxy gaps as antisense inhibitors of gene expression. J Biol Chem. 1993;268(19):14514–14522.
   PubMed Web of Science ®Google Scholar
• Burel SA, Han SR, Lee HS, et al. Preclinical evaluation of the toxicological effects of a novel constrained ethyl modified antisense compound targeting signal transducer and activator of transcription 3 in mice and cynomolgus monkeys. Nucleic Acid Ther. 2013;23(3):213–227.
   PubMed Web of Science ®Google Scholar
• Zielinski R, Chi KN. Custirsen (OGX-011): a second-generation antisense inhibitor of clusterin in development for the treatment of prostate cancer. Future Oncol. 2012;8(10):1239–1251.
   PubMed Web of Science ®Google Scholar
• Hong D, Kurzrock R, Kim Y, et al. AZD9150, a next-generation antisense oligonucleotide inhibitor of STAT3 with early evidence of clinical activity in lymphoma and lung cancer. Sci Transl Med. 2015;7(314):314ra185.
   PubMed Web of Science ®Google Scholar
• Yamamoto Y, Loriot Y, Beraldi E, et al. Generation 2.5 antisense oligonucleotides targeting the androgen receptor and its splice variants suppress enzalutamide-resistant prostate cancer cell growth. Clin Cancer Res. 2015;21(7):1675–1687.
   PubMed Web of Science ®Google Scholar
• Arun G, Diermeier S, Akerman M, et al. Differentiation of mammary tumors and reduction in metastasis upon Malat1 lncRNA loss. Genes Dev. 2016;30(1):34–51.
   PubMed Web of Science ®Google Scholar
• Mendell JT. Targeting a long noncoding RNA in breast cancer. N Engl J Med. 2016;374(23):2287–2289.
   PubMed Web of Science ®Google Scholar
• Disney MD. Targeting RNA with small molecules to capture opportunities at the intersection of chemistry, biology, and medicine. J Am Chem Soc. 2019;141(17):6776–6790.
   PubMed Web of Science ®Google Scholar
• Malouf GG, Taube JH, Lu Y, et al. Architecture of epigenetic reprogramming following Twist1-mediated epithelial-mesenchymal transition. Genome Biol. 2013;14(12):R144.
   PubMed Web of Science ®Google Scholar
• Taube JH, Malouf GG, Lu E, et al. Epigenetic silencing of microRNA-203 is required for EMT and cancer stem cell properties. Sci Rep. 2013;3:2687.
   PubMed Web of Science ®Google Scholar
• Shapiro IM, Cheng AW, Flytzanis NC, et al. An EMT-driven alternative splicing program occurs in human breast cancer and modulates cellular phenotype. PLoS Genet. 2011;7(8):e1002218.
   PubMed Web of Science ®Google Scholar
• Warzecha CC, Jiang P, Amirikian K, et al. An ESRP-regulated splicing programme is abrogated during the epithelial-mesenchymal transition. Embo J. 2010;29(19):3286–3300.
   PubMed Web of Science ®Google Scholar
• Taube JH, Herschkowitz JI, Komurov K, et al. Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes. Proc Natl Acad Sci USA. 2010;107(35):15449–15454.
   PubMed Web of Science ®Google Scholar
• Fustin JM, Doi M, Yamaguchi Y, et al. RNA-methylation-dependent RNA processing controls the speed of the circadian clock. Cell. 2013;155(4):793–806.
   PubMed Web of Science ®Google Scholar
• Geula S, Moshitch-Moshkovitz S, Dominissini D, et al. Stem cells. m6A mRNA methylation facilitates resolution of naive pluripotency toward differentiation. Science. 2015;347(6225):1002–1006.
   PubMed Web of Science ®Google Scholar
• Jia G, Fu Y, Zhao X, et al. N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO. Nature Chem Biol. 2011;7(12):885–887.
   PubMed Web of Science ®Google Scholar
• Lin S, Choe J, Du P, et al. The m(6)A methyltransferase METTL3 promotes translation in human cancer cells. Mol Cell. 2016;62(3):335–345.
   PubMed Web of Science ®Google Scholar
• Saletore Y, Meyer K, Korlach J, et al. The birth of the epitranscriptome: deciphering the function of RNA modifications. Genome Biol. 2012;13(10):175.
   PubMed Web of Science ®Google Scholar
• Satterlee JS, Basanta-Sanchez M, Blanco S, et al. Novel RNA modifications in the nervous system: form and function. J Neurosci. 2014;34(46):15170–15177.
   PubMed Web of Science ®Google Scholar
• Desrosiers R, Friderici K, Rottman F. Identification of methylated nucleosides in messenger RNA from Novikoff hepatoma cells. Proc Natl Acad Sci USA. 1974;71(10):3971–3975.
   PubMed Web of Science ®Google Scholar
• Wei CM, Gershowitz A, Moss B. 5ʹ-Terminal and internal methylated nucleotide sequences in HeLa cell mRNA. Biochemistry. 1976;15(2):397–401.
   PubMed Web of Science ®Google Scholar
• Agris PF. The importance of being modified: roles of modified nucleosides and Mg2+ in RNA structure and function. Prog Nucleic Acid Res Mol Biol. 1996;53:79–129.
   PubMed Web of Science ®Google Scholar
• Iwanami Y, Brown GM. Methylated bases of ribosomal ribonucleic acid from HeLa cells. Arch Biochem Biophys. 1968;126(1):8–15.
   PubMed Web of Science ®Google Scholar
• Bringmann P, Luhrmann R. Antibodies specific for N6-methyladenosine react with intact snRNPs U2 and U4/U6. FEBS Lett. 1987;213(2):309–315.
   PubMed Web of Science ®Google Scholar
• Kaur S, Lotsari-Salomaa JE, Seppanen-Kaijansinkko R, et al. MicroRNA methylation in colorectal cancer. Adv Exp Med Biol. 2016;937:109–122.
   PubMed Web of Science ®Google Scholar
• Cantara WA, Crain PF, Rozenski J, et al. The RNA modification database, RNAMDB: 2011 update. Nucl Acids Res. 2011;39(Database issue):D195–201.
   PubMedGoogle Scholar
• Machnicka MA, Milanowska K, Osman Oglou O, et al. MODOMICS: a database of RNA modification pathways–2013 update. Nucl Acids Res. 2013;41(Database issue):D262–267.
   PubMedGoogle Scholar
• Sibbritt T, Patel HR, Preiss T. Mapping and significance of the mRNA methylome. Wiley Interdiscip Rev RNA. 2013;4(4):397–422.
   PubMed Web of Science ®Google Scholar
• Lin X, Chai G, Wu Y, et al. RNA m(6)A methylation regulates the epithelial mesenchymal transition of cancer cells and translation of snail. Nat Commun. 2019;10(1):2065.
   PubMed Web of Science ®Google Scholar
• Yue B, Song C, Yang L, et al. METTL3-mediated N6-methyladenosine modification is critical for epithelial-mesenchymal transition and metastasis of gastric cancer. Mol Cancer. 2019;18(1):142.
   PubMed Web of Science ®Google Scholar